Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Acesis BioMed
AddedFeb 16, 2024
UpdatedJun 18, 2026
Acesis BioMed

Acesis BioMed

Pre-Seed

Acesis BioMed: Pioneering oral drug solutions for metabolic and endocrine disorders.

HQ
Denver, CO, US
Founded
2022
Overview
Compare
Fundraising
Employees
Website

Acesis BioMed, co-founded by Costas Karatzas and Vassilios Papadopoulos, is a biomedical company headquartered in Lone Tree, Colorado, with operations in both the USA and the UK. The company's core mission is to revolutionize the treatment of metabolic and endocrine disorders through the development of innovative oral drug candidates. Initially focusing on male hypogonadism (low testosterone), Acesis BioMed aims to provide effective and safe therapeutic solutions for patients suffering from these conditions.

Notable affiliated individuals include the co-founders, who bring extensive experience in biomedical research and development. Acesis BioMed operates under the umbrella of Acesis Holdings Corporation, with subsidiaries in both the US and UK. The company has made significant strides in developing its drug platform, emphasizing safety and efficacy. Its impact is marked by its pioneering approach to treating hypogonadism and related co-morbidities, positioning Acesis BioMed as a key player in the field of metabolic and endocrine disorder treatments.

Acesis BioMed - Similar Companies

Marius Pharmaceuticals logo

Marius Pharmaceuticals

mariuspharma.com

CiVi Biopharma logo

CiVi Biopharma

civibio.com

Accuitis logo

Accuitis

accuitis.com

OrsoBio logo

OrsoBio

orsobio.com

Equator Therapeutics logo

Equator Therapeutics

Actio Biosciences logo

Actio Biosciences

actiobio.com

Tabomedex logo

Tabomedex

tabomedex.com

Thetis Pharmaceuticals logo

Thetis Pharmaceuticals

thetispharma.com

Agentix logo

Agentix

agentixcorp.com

Energesis Pharmaceuticals logo

Energesis Pharmaceuticals

Akelos logo

Akelos

akelosinc.com

Bond Biosciences logo

Bond Biosciences

bond.bio

Intellimedix logo

Intellimedix

MBX Biosciences logo

MBX Biosciences

mbxbio.com

Aesthetics Biomedical logo

Aesthetics Biomedical

Acesis BioMed - Quick Facts

Who are Acesis BioMed's competitors?

Companies similar to Acesis BioMed include Marius Pharmaceuticals, CiVi Biopharma, Accuitis and OrsoBio.

When was Acesis BioMed founded?

Acesis BioMed was founded in 2022.

Where is Acesis BioMed's headquarters located?

Acesis BioMed's headquarters is located in Denver, CO, US.

When was Acesis BioMed's last funding round?

Acesis BioMed's most recent funding round was for $1.3M (USD) in January 2023.

How much has Acesis BioMed raised to-date?

As of Jan 11, 2023, Acesis BioMed has raised a total of $1.3M (USD).

How many employees does Acesis BioMed have?

Acesis BioMed has 2 employees as of Feb 4, 2024.

Acesis BioMed - Classification

Ownership
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Drug Development
Tags
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 12 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified